1 To characterize the muscarinic receptors on human pulmonary veins associa
ted with the acetylcholine (ACh)-induced relaxation, isolated venous and ar
terial preparations were precontracted with noradrenaline (10 mu M) and wer
e subsequently challenged with ACh in the absence or presence of selective
muscarinic antagonists.
2 ACh relaxed venous preparations derived from human lung with a pD(2) valu
e of 5.82+-0.09 (n = 16). In venous preparations when the endothelium had b
een removed, the ACh relaxations were abolished (n = 4). ACh relaxed arteri
al preparations with a pD(2) value of 7.06+/-0.14 (n = 5).
3 Atropine (1 mu M), the non selective antagonist for muscarinic receptors,
inhibited ACh-induced relaxations;in human pulmonary veins. The affinity v
alue (pK(B) value) for atropine was: 8.64+/-0.10 (n = 5). The selective mus
carinic antagonists (darifenacin (M-3), himbacine (M-2,M-4), methoctramine
(M-2) and pFHHSiD (M-1,M-3)) also inhibited ACh-induced relaxations in veno
us preparations. The pKB values obtained for these antagonists were not tho
se predicted for the involvement of M2-5, receptors in the ACh-induced rela
xation in human pulmonary veins.
4 The pK(B) value for darifenacin (1 mu M) was significantly greater in hum
an pulmonary arterial (8.63+/-0.14) than in venous (7.41+/-0.20) preparatio
ns derived from three lung samples.
5 In human pulmonary veins, the pKB values for pirenzepine (0.5 and 1 mu M)
, a selective antagonist for M-1 receptors, were: 7.89+/-0.24 (n = 7) and 8
.18+/-0.22 (n = 5), respectively. In the venous preparations, the pK(B) val
ues derived from the functional studies with all the different muscarinic a
ntagonists used were correlated (r = 0.89; P = 0.04; slope = 0.78) with the
affinity values (pK(i) values) previously published for human cloned mi re
ceptors in CHO cells.
6 These results suggest that the relaxations induced by ACh are due to the
activation of M-1 receptors on endothelial cells in isolated human pulmonar
y veins.